The MiningNewsWire Podcast

One of the most pervasive diseases in first-world countries, heart disease is the leading cause of death for men and women of most racial and ethnic groups in the United States, with one person dying every 36 seconds from cardiovascular disease. According to the Centers for Disease Control and Prevention (“CDC”), high blood pressure, or hypertension, is a key risk factor for both heart disease and stroke, and nearly half of all adults in the United States, or 108 million, have hypertension — yet only about 24% of those have their condition under control. Many don’t even know they have it. The urgency of finding effective treatments for this life-threatening disease can’t be understated, with many companies, including Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile), with its patented DehydraTECH(TM) drug delivery, joining the effort to offer safe, effective and affordable treatments. Hypertension and related conditions are also points of focus for other drug-making juggernauts such as Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), Novartis AG (NYSE: NVS) and AstraZeneca PLC (NASDAQ: AZN).

One of the most pervasive diseases in first-world countries, heart disease is the leading cause of death for men and women of most racial and ethnic groups in the United States, with one person dying every 36 seconds from cardiovascular disease. According to the Centers for Disease Control and Prevention (“CDC”), high blood pressure, or hypertension, is a key risk factor for both heart disease and stroke, and nearly half of all adults in the United States, or 108 million, have hypertension — yet only about 24% of those have their condition under control. Many don’t even know they have it. The urgency of finding effective treatments for this life-threatening disease can’t be understated, with many companies, including Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile), with its patented DehydraTECH(TM) drug delivery, joining the effort to offer safe, effective and affordable treatments. Hypertension and related conditions are also points of focus for other drug-making juggernauts such as Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), Novartis AG (NYSE: NVS) and AstraZeneca PLC (NASDAQ: AZN).

In July 2012, Congress created what is known as Breakthrough Therapy designation, a distinction that affords biotechnology and pharmaceutical companies an expedited review process for experimental drugs that may have treatment advantages over existing therapies for hard-to-treat diseases. In November 2013, Gazyva, a drug used in combination with chlorambucil for patients with chronic lymphocytic leukemia, made history as the first breakthrough therapy to receive FDA marketing approval. Since then, hundreds of drugs have earned the designation, and several have reached commercialization. An area that remains underrepresented on the FDA breakthrough therapy list that could make waves in the coming years is that of the emerging market of psychedelics, where companies such as Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (Profile) is striving to provide relief for patients with chronic pain by developing evidence-based innovation in areas where today’s approved drugs and therapies are lacking. Tryp is part of a select group of companies that are advancing or have already advanced psychedelic treatments into Phase 2 of the FDA clinical trial process, a small collection of impressive companies that includes COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), ATAI Life Sciences N.V. (NASDAQ: ATAI) and Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF).

The $150-billion global advertising industry is looking for answers during a shakeup that has cable television charting a course emblematic of the Golden Age of Radio a century ago. Owing to the confluence of cord cutters, DVRs allowing people to skip commercials and an off-year for elections among other things, local TV ad revenue has been sinking in 2021. Now more than ever, brands are forced to keenly monitor marketing trends and adjust strategies that increasingly point toward digital solutions to reach consumers. Working with content creators and influencers, those people (and things) on social media with a large or specific group of followers that can be swayed into purchases by compelling messaging, appears to be particularly effective. By now, most people are aware of marketing via a personality, such as Kim Kardashian who can influence her followers to try a particular product. While that still has its place, the market is far more evolved and sophisticated today, with companies such as Clubhouse Media Group Inc. (OTC: CMGR) (Profile) aggregating an impressive collection of influencers and content creators with hundreds of millions of followers and combining that community with technology as a platform for collaboration and creation. That type of dynamic is a win-win for advertisers and the world’s most popular social media apps and sites, including Facebook Inc. (NASDAQ: FB), Pinterest Inc. Class A (NYSE: PINS), Snap Inc. Class A (NYSE: SNAP) and Twitter Inc. (NYSE: TWTR).

The $150-billion global advertising industry is looking for answers during a shakeup that has cable television charting a course emblematic of the Golden Age of Radio a century ago. Owing to the confluence of cord cutters, DVRs allowing people to skip commercials and an off-year for elections among other things, local TV ad revenue has been sinking in 2021. Now more than ever, brands are forced to keenly monitor marketing trends and adjust strategies that increasingly point toward digital solutions to reach consumers. Working with content creators and influencers, those people (and things) on social media with a large or specific group of followers that can be swayed into purchases by compelling messaging, appears to be particularly effective. By now, most people are aware of marketing via a personality, such as Kim Kardashian who can influence her followers to try a particular product. While that still has its place, the market is far more evolved and sophisticated today, with companies such as Clubhouse Media Group Inc. (OTC: CMGR) (Profile) aggregating an impressive collection of influencers and content creators with hundreds of millions of followers and combining that community with technology as a platform for collaboration and creation. That type of dynamic is a win-win for advertisers and the world’s most popular social media apps and sites, including Facebook Inc. (NASDAQ: FB), Pinterest Inc. Class A (NYSE: PINS), Snap Inc. Class A (NYSE: SNAP) and Twitter Inc. (NYSE: TWTR).

In July 2012, Congress created what is known as Breakthrough Therapy designation, a distinction that affords biotechnology and pharmaceutical companies an expedited review process for experimental drugs that may have treatment advantages over existing therapies for hard-to-treat diseases. In November 2013, Gazyva, a drug used in combination with chlorambucil for patients with chronic lymphocytic leukemia, made history as the first breakthrough therapy to receive FDA marketing approval. Since then, hundreds of drugs have earned the designation, and several have reached commercialization. An area that remains underrepresented on the FDA breakthrough therapy list that could make waves in the coming years is that of the emerging market of psychedelics, where companies such as Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (Profile) is striving to provide relief for patients with chronic pain by developing evidence-based innovation in areas where today’s approved drugs and therapies are lacking. Tryp is part of a select group of companies that are advancing or have already advanced psychedelic treatments into Phase 2 of the FDA clinical trial process, a small collection of impressive companies that includes COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), ATAI Life Sciences N.V. (NASDAQ: ATAI) and Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF).

Cryptocurrency mining, where banks of specialized computers rush to solve complex algorithms and build data blocks of transaction activity on the blockchain to earn cryptocurrency, is energy intensive, to say the least. From the outset, China kept a stranglehold on the market owing to abundant and cheap energy, including in the coal plant hubs of inner Mongolia and Xinjiang, resulting in more than half of the world’s mining activity occurring in the country. However, Beijing is facing pressure to control carbon emissions, and it is pointing its finger directly at cryptomining for its failure to meet targets. To that end, Chinese regulators have taken unprecedented action in shutting down crypto miners, shining a spotlight on cleaner energy solutions, like those offered by ISW Holdings Inc. (OTC: ISWH) (Profile), which just got a head start in a race for power in the United States. The Chinese shutdown also means that all those coins that would have been mined by Chinese firms are up for grabs, which is good news for ISWH and crypto miners such as Marathon Digital Holdings Inc. (NASDAQ: MARA), CleanSpark Inc. (NASDAQ: CLSK), Riot Blockchain Inc (NASDAQ: RIOT) and Bitfarms Ltd. (NASDAQ: BITF).

Cryptocurrency mining, where banks of specialized computers rush to solve complex algorithms and build data blocks of transaction activity on the blockchain to earn cryptocurrency, is energy intensive, to say the least. From the outset, China kept a stranglehold on the market owing to abundant and cheap energy, including in the coal plant hubs of inner Mongolia and Xinjiang, resulting in more than half of the world’s mining activity occurring in the country. However, Beijing is facing pressure to control carbon emissions, and it is pointing its finger directly at cryptomining for its failure to meet targets. To that end, Chinese regulators have taken unprecedented action in shutting down crypto miners, shining a spotlight on cleaner energy solutions, like those offered by ISW Holdings Inc. (OTC: ISWH) (Profile), which just got a head start in a race for power in the United States. The Chinese shutdown also means that all those coins that would have been mined by Chinese firms are up for grabs, which is good news for ISWH and crypto miners such as Marathon Digital Holdings Inc. (NASDAQ: MARA), CleanSpark Inc. (NASDAQ: CLSK), Riot Blockchain Inc (NASDAQ: RIOT) and Bitfarms Ltd. (NASDAQ: BITF).

Global Extended Reality Market size expected to grow from 33 billion USD in 2021 to over 125 billion USD in 2026, at CAGR of 30%

US online sports betting market size expected to grow at 50% CAGR to reach 15 billion by 2025

Online gambling market size expected to grow at 11.5% CAGR to reach 127 billion USD by 2027

XR Casino, Inc. (“XR Casino” or “The Company”), the first-ever cross-technology, multiplayer, blockchain technology-based online gambling platform for Extended Reality (“XR”) technologies such as Augmented Reality (“AR”), Mixed Reality (“MR”) and Virtual Reality (“VR”), today announces its MVP release date.

To read the original press release, visit: https://nnw.fm/10QVT

Rritual Superfoods Inc. ("Rritual" or the "Company") (CSE: RSF) (FSE: 0RW) (OTC: RRSFF), a fast-growing functional superfood company that creates natural wellness products which support a holistic approach to a healthy lifestyle, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Rritual's recent announcement that its premium brand of functional superfoods will launch in CVS stores across the USA.

To hear the audio production, visit: https://www.nnw.fm/bFP7j

To read the original press release, visit: https://www.nnw.fm/V9sYE

Rritual Superfoods Inc. ("Rritual" or the "Company") (CSE: RSF) (FSE: 0RW) (OTC: RRSFF), a fast-growing functional superfood company that creates natural wellness products which support a holistic approach to a healthy lifestyle, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Rritual's recent announcement that its premium brand of functional superfoods will launch in CVS stores across the USA.

To hear the audio production, visit: https://www.nnw.fm/bFP7j

To read the original press release, visit: https://www.nnw.fm/V9sYE

In May 2013, GW Pharma listed on Nasdaq, selling 3.5 million shares at $8.90 each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds. Legal cannabis was only beginning to gain momentum at that time, and while countless companies saturated the market as would-be growers, distributors, etc., GW was taking a more difficult route of drug development with much greater upside if successful. The strategy paid off as the company received FDA approval for the first-ever cannabis-based drug in June 2018. There are some notable similarities between the evolution of the legal cannabis market a decade ago and the current status of psychedelics, longtime illicit drugs that are now being evaluated for their therapeutic potential by a handful of upstart companies. San Diego-based Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (Profile) stands out, not only for its still-small valuation but also because it has a successful management team that, much like GW, is charting its own course in the space. Major investors have not been shy about speculating that biotech is going to produce some psychedelic-derived blockbusters, as evidenced by the attention given to COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine (“MindMed”) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) and newly public ATAI Life Sciences N.V. (NASDAQ: ATAI), any one of which could do for psychedelics what GW Pharmaceuticals (NASDAQ: GWPH) did for cannabis before being acquired in February by Jazz Pharmaceuticals plc (NASDAQ: JAZZ) for $7.2 billion.

Food waste is a major problem at multiple levels, whether it has to do with the consumer, supply chain, grocery or, ultimately at the food’s end of life, landfill. It’s a problem that all too often goes ignored, unnoticed and underserved, contributing negatively to food security, the environment and even climate change. The amount of food waste in America alone is simply mind numbing, weighing in at 133 billion pounds and $161 billion worth of food in 2010. That means 31% of all food produced annually is wasted. As a subcategory, 644 million tons of fruit and vegetables, or 42% of total supply, is wasted annually. In 2015, the U.S. Department of Agriculture (“USDA”) joined with the U.S. Environmental Protection Agency (“EPA”) to cut U.S. food waste by 50% by the year 2030. That seems an obtainable goal when technology combines with focus and support. Technology efforts include natural solutions to increase food longevity offered by agri-food-tech Save Foods Inc. (NASDAQ: SVFD) (Profile); focused efforts include governmental support such as that offered by the USDA and EPA, as well as industry assistance coming from major grocery chains such as Walmart Inc. (NYSE: WMT), Costco Wholesale Corporation (NASDAQ: COST), Target Corporation (NYSE: TGT) and Loblaw Cos. Ltd. (TSX: L) (OTC: LBLCF).

Food waste is a major problem at multiple levels, whether it has to do with the consumer, supply chain, grocery or, ultimately at the food’s end of life, landfill. It’s a problem that all too often goes ignored, unnoticed and underserved, contributing negatively to food security, the environment and even climate change. The amount of food waste in America alone is simply mind numbing, weighing in at 133 billion pounds and $161 billion worth of food in 2010. That means 31% of all food produced annually is wasted. As a subcategory, 644 million tons of fruit and vegetables, or 42% of total supply, is wasted annually. In 2015, the U.S. Department of Agriculture (“USDA”) joined with the U.S. Environmental Protection Agency (“EPA”) to cut U.S. food waste by 50% by the year 2030. That seems an obtainable goal when technology combines with focus and support. Technology efforts include natural solutions to increase food longevity offered by agri-food-tech Save Foods Inc. (NASDAQ: SVFD) (Profile); focused efforts include governmental support such as that offered by the USDA and EPA, as well as industry assistance coming from major grocery chains such as Walmart Inc. (NYSE: WMT), Costco Wholesale Corporation (NASDAQ: COST), Target Corporation (NYSE: TGT) and Loblaw Cos. Ltd. (TSX: L) (OTC: LBLCF).

In May 2013, GW Pharma listed on Nasdaq, selling 3.5 million shares at $8.90 each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds. Legal cannabis was only beginning to gain momentum at that time, and while countless companies saturated the market as would-be growers, distributors, etc., GW was taking a more difficult route of drug development with much greater upside if successful. The strategy paid off as the company received FDA approval for the first-ever cannabis-based drug in June 2018. There are some notable similarities between the evolution of the legal cannabis market a decade ago and the current status of psychedelics, longtime illicit drugs that are now being evaluated for their therapeutic potential by a handful of upstart companies. San Diego-based Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (Profile) stands out, not only for its still-small valuation but also because it has a successful management team that, much like GW, is charting its own course in the space. Major investors have not been shy about speculating that biotech is going to produce some psychedelic-derived blockbusters, as evidenced by the attention given to COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine (“MindMed”) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) and newly public ATAI Life Sciences N.V. (NASDAQ: ATAI), any one of which could do for psychedelics what GW Pharmaceuticals (NASDAQ: GWPH) did for cannabis before being acquired in February by Jazz Pharmaceuticals plc (NASDAQ: JAZZ) for $7.2 billion.

There’s plenty of prattle out there about global warming and sustainable energy, most of which is unrealistic and lacking in real-world achievability. As it stands now, the world is aligned to fall demonstrably short of a unitary goal to reach net zero emissions by 2050. Indeed, there are many noble intentions underscoring proposals to curb CO2 emissions, but the economic cost and technological challenges make it more platitude than practical. Last month, the International Energy Agency (“IEA”) issued a comprehensive and actionable plan to cap the global temperature rise to 1.5°C by mid-century without upending energy stability, accessibility or pricing. IEA covers it all and lays out how renewable energies in combination with nuclear power will become the dominant energy sources across the planet even amid a growing global population. The transition is inevitable for the planet’s survival, and there are ways to capitalize on this titanic transformation in the energy sector. In the United States, Uranium Energy Corp. (NYSE American: UEC) (Profile) is a  leading player in low-cost and environmentally friendly in-situ recovery (“ISR”) mining of uranium, the essential element that fuels nuclear energy. There are exchange-traded funds, namely iShares S&P Global Clean Energy Index Fund (NASDAQ: ICLN) and direct plays such as First Solar Inc. (NASDAQ: FSLR) and Tesla Inc. (NASDAQ: TSLA). For those preferring a different approach to the EV space, a close look at top copper producer Freeport-McMoRan Inc. (NYSE: FCX) may be in order.

There’s plenty of prattle out there about global warming and sustainable energy, most of which is unrealistic and lacking in real-world achievability. As it stands now, the world is aligned to fall demonstrably short of a unitary goal to reach net zero emissions by 2050. Indeed, there are many noble intentions underscoring proposals to curb CO2 emissions, but the economic cost and technological challenges make it more platitude than practical. Last month, the International Energy Agency (“IEA”) issued a comprehensive and actionable plan to cap the global temperature rise to 1.5°C by mid-century without upending energy stability, accessibility or pricing. IEA covers it all and lays out how renewable energies in combination with nuclear power will become the dominant energy sources across the planet even amid a growing global population. The transition is inevitable for the planet’s survival, and there are ways to capitalize on this titanic transformation in the energy sector. In the United States, Uranium Energy Corp. (NYSE American: UEC) (Profile) is a  leading player in low-cost and environmentally friendly in-situ recovery (“ISR”) mining of uranium, the essential element that fuels nuclear energy. There are exchange-traded funds, namely iShares S&P Global Clean Energy Index Fund (NASDAQ: ICLN) and direct plays such as First Solar Inc. (NASDAQ: FSLR) and Tesla Inc. (NASDAQ: TSLA). For those preferring a different approach to the EV space, a close look at top copper producer Freeport-McMoRan Inc. (NYSE: FCX) may be in order.

Even though medical marijuana had been legal in some U.S. states for more than a decade, the substance didn’t gain much recognition until Colorado set the market on its head in 2012 by making adult-use marijuana legal. Since then, other states have followed suit, while in 2018, Canada went all-in to become the first developed nation with weed legalized at the federal level. Not surprisingly, North American companies and investors were tripping over themselves trying to capitalize on the massive burgeoning market. In all market segments, plenty of lessons were learned as everyone from companies to investors to lawmakers worked to organize a brand new market; lessons that the new generation of multistate operators such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) (Profile) have leveraged to more efficiently execute their business models. RWB is following in the footsteps of large first movers such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and Cresco Labs (CSE: CL) (OTCQX: CRLBF), companies that survived the early days to hold valuations in the billions of dollars.

Even though medical marijuana had been legal in some U.S. states for more than a decade, the substance didn’t gain much recognition until Colorado set the market on its head in 2012 by making adult-use marijuana legal. Since then, other states have followed suit, while in 2018, Canada went all-in to become the first developed nation with weed legalized at the federal level. Not surprisingly, North American companies and investors were tripping over themselves trying to capitalize on the massive burgeoning market. In all market segments, plenty of lessons were learned as everyone from companies to investors to lawmakers worked to organize a brand new market; lessons that the new generation of multistate operators such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) (Profile) have leveraged to more efficiently execute their business models. RWB is following in the footsteps of large first movers such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and Cresco Labs (CSE: CL) (OTCQX: CRLBF), companies that survived the early days to hold valuations in the billions of dollars.

Emaginos, a company in the business of transforming K-12 public education, announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers the recent announcement regarding the filing of a provisional patent application with the United States Patent and Trademark Office (“USPTO”) for its proprietary EdManage platform, an analytics platform that aggregates and analyzes all of a school district’s data to deliver actionable information to users throughout the system.

To read the original press release, visit: https://www.nnw.fm/oYbV8